What is Comet Bio?
Comet Bio operates as a specialized food technology enterprise with dual headquarters in London, Ontario, and Schaumburg, Illinois. The firm is primarily recognized for its patented upcycling processes that convert agricultural waste into premium, functional ingredients. Its flagship product, Arrabina, serves as a high-tolerability prebiotic dietary fiber, while its Sweeterra syrup line offers a sustainable, lower-sugar alternative to conventional sweeteners. By bridging the gap between agricultural efficiency and consumer health, Comet Bio addresses critical supply chain challenges while meeting the evolving preferences of health-conscious consumers and food manufacturers alike.
How much funding has Comet Bio raised?
Comet Bio has raised a total of $22M across 1 funding round:
Series C
$22M
Series C (2021): $22M with participation from Open Prairie Ventures, Louis Dreyfus Company, BDC Capital, and Sofinnova Partners
Key Investors in Comet Bio
Open Prairie Ventures
Open Prairie is a private equity fund management firm with a strong focus on agriculture and rural America, aiming to enhance capital accessibility in underserved markets.
Louis Dreyfus Company
Louis Dreyfus Company is a global merchant and processor of agricultural goods, specializing in food, beverages, proteins, and bioenergy ingredients.
BDC Capital
BDC Capital provides supplemental financing and financial services, including equity investments and loans, to support the growth of emerging companies.
What's next for Comet Bio?
With the successful closure of this major strategic investment, Comet Bio is well-positioned to accelerate its commercial expansion and deepen its market penetration. The company is expected to leverage this capital to scale its production capabilities, ensuring that its upcycled ingredients can meet the rigorous demands of large-scale food and beverage manufacturers. Future growth initiatives will likely focus on expanding the distribution of its Sweeterra and Arrabina product lines, while simultaneously exploring new applications for its proprietary technology. As the company transitions into this next phase of maturity, the focus will remain on optimizing operational efficiencies and solidifying its role as a key supplier in the global sustainable food ingredient ecosystem.
See full Comet Bio company page
